The effect of the non-NMDA receptor antagonists GYKI 52466 and NBQX and the competitive NMDA receptor antagonist d-CPPene on the development of amygdala kindling and on amygdala-kindled seizures
- 1 February 1994
- journal article
- Published by Elsevier in Epilepsy Research
- Vol. 17 (2) , 167-174
- https://doi.org/10.1016/0920-1211(94)90016-7
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Roles of the NMDA and quisqualate/kainate receptors in the induction and expression of kindled bursts in rat hippocampal slicesEpilepsy Research, 1993
- A synaptic model of memory: long-term potentiation in the hippocampusNature, 1993
- The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in miceEpilepsy Research, 1991
- Potent oral anticonvulsant action of CPP and CPPene in DBA/2 miceEuropean Journal of Pharmacology, 1990
- Retardation of amygdala kindling by antagonism of NMD-aspartate and muscarinic cholinergic receptors: Evidence for the summation of excitatory mechanisms in kindlingExperimental Neurology, 1988
- Ketamine-induced changes in kindled amygdaloid seizuresNeuropharmacology, 1983
- Phencyclidine inhibition of the rate of development of amygdaloid kindled seizuresExperimental Neurology, 1982
- Development of a New Pharmacological Seizure Model: Effects of Anticonvulsants on Cortical‐and Amygdala‐Kindled Seizures in the RatEpilepsia, 1980
- Pharmacological modification of amygdaloid-kindled seizuresNeuropharmacology, 1980
- Anticonvulsant drugs and their antagonism of kindled amygdaloid seizures in ratsNeuropharmacology, 1980